Arkolith/Insider Trading/PRDS/Form 4

Wiggans Thomas G

Chief Executive Officer, DirectorPARDES BIOSCIENCES, INC. (PRDS) · full profile →Form 4 · filed Dec 5, 2022
Net Buying
Open-Market Buys
$39K
Open-Market Sells
$0
Net Open-Market Flow
$39K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2022Buy(P)13K$1.07$13K38K
Dec 1, 2022Buy(P)25K$1.04$26K25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-059677) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML